アルツハイマー病認知症患者におけるMK-1167の有効性と安全性を評価する試験（MK-1167-008）

基本情報

NCT ID: NCT06721156
ステータス: 募集中
試験のフェーズ: 第2相
試験タイプ: 介入
目標被験者数: 350
治験依頼者名: Merck Sharp & Dohme LLC

概要

Researchers want to learn if giving MK-1167 (the study medicine) along with acetylcholinesterase inhibitor (AChEI) therapy can improve symptoms of Alzheimer's disease dementia (AD dementia), such as memory and mental activity. AD dementia is the most common type of dementia. AChEI therapy is the standard treatment for AD dementia. The goals of this study are to learn: * If at least one dose level (amount) of MK-1167 works to improve a person's memory and thinking compared to a placebo * About the safety of MK-1167 and if people tolerate it

対象疾患

アルツハイマー病痴呆

介入

MK-1167(DRUG)

Placebo(DRUG)

依頼者（Sponsor）

MSD株式会社(INDUSTRY)

実施施設 (15)

Nozomi Memory Clinic ( Site 1504)

Mitaka, Tokyo, Japan(RECRUITING)

Nozomi Memory Clinic ( Site 1504)

Mitaka, Tokyo, Japan(RECRUITING)

Takesato Hospital ( Site 1522)

Kasukabe, Saitama, Japan(RECRUITING)

Takesato Hospital ( Site 1522)

Kasukabe, Saitama, Japan(RECRUITING)

Iwaki Clinic ( Site 1518)

Anan, Tokushima, Japan(ACTIVE_NOT_RECRUITING)

Itsuki Hospital ( Site 1502)

Tokushima, Japan(RECRUITING)

地方独立行政法人東京都健康長寿医療センター

tabashi City, Tokyo, Japan(RECRUITING)

川崎医療生活協同組合川崎協同病院

Kawasaki, Kanagawa, Japan(RECRUITING)

和水クリニック

Toyonaka, Osaka, Japan(ACTIVE_NOT_RECRUITING)

Nagomi Clinic ( Site 1506)

Toyonaka, Osaka, Japan(ACTIVE_NOT_RECRUITING)

Iwaki Clinic ( Site 1518)

Anan, Tokushima, Japan(ACTIVE_NOT_RECRUITING)

医療法人　社団公仁会　城クリニック

Kawasaki, Kanagawa, Japan(RECRUITING)

脳神経内科はつたクリニック

Hirakata, Osaka, Japan(RECRUITING)

さくらい循環器・内科クリニック

Chōfu, Tokyo, Japan(RECRUITING)

Itsuki Hospital ( Site 1502)

Tokushima, Japan(RECRUITING)